课题基金 / 基金详情

EXPRESSION OF HIV ANTIGENS IN E COLI

EXPRESSION OF HIV ANTIGENS IN E COLI
HIV 抗原在大肠杆菌中的表达
批准号:
3804789
负责人:
C J MARCUS-SEKURA
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

C J MARCUS-SEKURA的其他基金

相似基金

相关文献

中文摘要
翻译
HIV整合酶(IN)是整合病毒DNA所需的病毒酶
英文摘要
HIV integrase (IN) is a viral enzyme required for integration of virus DNA into the host chromosome. This type of integration is highly specific for retroviruses, and HIV-1 IN is therefore a target for antiviral therapy. To design antivirals, it is essential to characterize IN. We have expressed the IN gene in E. coli as a fusion protein containing 23 amino acids of RT and all of IN. The cloned IN was reactive with both HIV-1 and HIV-2 positive sera. The recombinant protein was purified and used to immunize rabbits. The rabbit antisera are reactive with HIV-1 IN but not HIV-2 IN by Western blot, and also reactive with RT indicating that an antigenic epitope is present in the terminal 23 amino acids of RT. These data have recently been published in AIDS Research and Human Retroviruses (1990). In addition, 21 hybridomas have been prepared using the IN expressing clone and subcloned twice. 19 of these mAbs have specificity for IN and 2 for RT; all are IgG1, and all are reactive with HIV-1 but not HIV-2 by Western blot. An invention report has been filed and a manuscript is in preparation. An additional clone expressing only IN sequence has been constructed using PCR, as well as clones expressing the N- and C-terminal halves of IN. These clones have been examined for ability to bind DNA using a Southwestern blotting procedure. The complete IN molecule as well as the C-terminal protein bind DNA; the N-terminal portion exhibits no binding activity, suggesting that the C-terminal region contains the DNA binding site. A manuscript describing these findings is in preparation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOLOGIC ANALYSIS OF A HERPES VIRUS GLYCOPROTEIN VACCINE CANDIDATE--EBV GP350
  • 批准号:
    3770329
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C J MARCUS-SEKURA
  • 依托单位:
    --
EXPRESSION OF HIV ANTIGENS IN E COLI
  • 批准号:
    3811240
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C J MARCUS-SEKURA
  • 依托单位:
    --
DETECTION OF VIRUSES IN CELL SUBSTRATES
  • 批准号:
    3792523
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C J MARCUS-SEKURA
  • 依托单位:
    --
DETECTION OF VIRUSES IN CELL SUBSTRATES
  • 批准号:
    3804796
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    C J MARCUS-SEKURA
  • 依托单位:
    --
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: